Other
Piperidine salts and other piperidine derivatives
HSN 2933 32 90 (Other piperidine salts and derivatives) is subject to Central Drugs Standard Control Organisation (CDSCO) registration requirements under G.S.R. 102(E) dated 11-02-2020 for any variant listed as a medical device, and to mandatory registration or import permit under Section 9 of the Insecticides Act administered by the Central Insecticides Board and Registration Committee (CIB&RC) where the substance is intended for insecticidal use. Narcotic Drugs and Psychotropic Substances (NDPS) policy conditions 2 and 3 of Chapter 29, Ministry of Environment, Forest and Climate Change (MEFCC) hazardous-substance insurance obligations, and CBIC Chapter 29 mandatory qualifier requirements apply as additional clearance overlays.
- Registration certificate from CDSCO
- Import permit from CIB&RC
- Chapter 29 qualifiers from CBIC
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade, Central Board of Indirect Taxes and Customs.
- 1Determine the end-use of the piperidine derivative before filing. If classified as a medical device under G.S.R. 102(E) dated 11-02-2020, obtain CDSCO registration and comply with all conditions specified therein. If intended for insecticidal, rodenticidal, fungicidal, or herbicidal use, obtain CIB&RC registration or an import permit under Section 9 of the Insecticides Act; import is restricted to sources specified on the registration certificate or permit.G.S.R. 102(E) dated 11-02-2020 (MOHFW) · Section 9, Insecticides Act · Rule 45, Insecticides Rules, 1971 · CBIC Circulars 35/2011 dated 09-08-2011 and 7/2014 dated 07-03-2014
- 2Comply with CBIC Circular 23/2023-Cus dated 30-09-2023 by submitting mandatory additional qualifiers in the import declaration for Chapter 29 commodities, as stipulated in para 4.1 and 4.2, with effect from 15-10-2023. Additionally, if the consignment involves narcotic drugs or psychotropic substances covered under Chapter 29, comply with NDPS policy conditions 2 and 3.CBIC Circular 23/2023-Cus dated 30-09-2023 · ITC (HS) Chapter 29, policy conditions 2 and 3 · DGFT Notification 44/2025-26 dated 15-10-2025
- 3If importing specified hazardous substances exceeding the prescribed quantities, take out a public liability insurance policy under the Public Liability Insurance Act, 1991. For imports involving ozone-depleting substances, ensure compliance with policy conditions 1, 4 and 5 of Chapter 29 and Para 8(a) of the General Notes per the Ozone Depleting Substances (Regulation and Control) Rules, 2000.S.O. 227(E) dated 24-03-1992 (MOEF) · ITC (HS) Chapter 29, policy conditions 1, 4 and 5 · Ozone Depleting Substances (Regulation and Control) Rules, 2000
The most common error on this tariff line is treating a single end-use characterisation as definitive when piperidine derivatives can simultaneously trigger CDSCO medical-device registration, CIB&RC insecticidal-use licensing, and NDPS policy conditions — each backed by independent enforcement authority. A consignment cleared under one regulatory track but used in another constitutes a separate contravention; customs officers cross-checking the Chapter 29 mandatory qualifiers against the declared end-use at bill-of-entry stage will flag discrepancies, and the Public Liability Insurance obligation for hazardous-quantity imports is frequently overlooked until the consignment is detained.